Digital Trials Digest, our quarterly newsletter
A quarterly look at what's new in ObvioGo, where decentralized trials are heading, and the partnerships shaping what's next — new Image Capture & Central Rating features, caregiver-collected growth data research, and what's coming in OG-2.10.
Issue 2: new Assent & Countersignature capabilities, ObvioGo's direct integration with Oracle Health and Life Sciences, Novotech's multi-trial licensing agreement, and SCOPE 2026 takeaways.
Issue 1: ObvioGo's new built-in eSignature, the Template Library and Out-of-Window Data Submissions features, caregiver-centric eDiary design, and how MiHelper accelerated a decentralized migraine study.
AI, patient advocacy groups, digital health technologies, and more. Here’s everything you need to know about the clinical trial trends of 2024—and how they’re reshaping the industry.
The FDA’s PFDD guidance series is a much-needed update to the PRO guidance released in 2009. But, what do these new recommendations mean for electronic data capture in clinical trials? Here’s what you need to know.
Artificial intelligence (AI) is transforming the landscape of patient engagement in clinical trials. Here’s everything you need to know.
Virtual clinical trials (VCTs) are a transformative approach to clinical research that's gaining momentum in the life sciences industry.
ePROs, or electronic patient-reported outcomes, play an essential role in clinical trials, illuminating patients' lived experiences.